华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300110 华仁药业

已收盘 01-13 15:00:00

{"stockData":{"symbol":"300110","market":"SZ","secType":"STK","nameCN":"华仁药业","latestPrice":3.34,"timestamp":1768287810000,"preClose":3.29,"halted":0,"volume":48482824,"delay":0,"changeRate":0.0152,"floatShares":1181000000,"shares":1182000000,"eps":-1.1922,"marketStatus":"已收盘","change":0.05,"latestTime":"01-13 15:00:00","open":3.29,"high":3.42,"low":3.28,"amount":163000000,"amplitude":0.0426,"askPrice":3.34,"askSize":6825,"bidPrice":3.33,"bidSize":3641,"shortable":0,"etf":0,"ttmEps":-1.1922,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":3.29,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":3.62,"lowLimit":2.96,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1182212982,"isCdr":false,"pbRate":2.87,"roa":"--","roe":"4.11%","epsLYR":-1.1576,"committee":0.056717,"marketValue":3949000000,"turnoverRate":0.0411,"status":0,"floatMarketCap":3944000000},"requestUrl":"/m/hq/s/300110","defaultTab":"news","newsList":[{"id":"2602557136","title":"股市必读：1月9日华仁药业现1笔折价10.09%的大宗交易 合计成交88.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602557136?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:33","pubTimestamp":1768156388,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，华仁药业报收于3.27元，上涨0.62%，换手率1.9%，成交量22.49万手，成交额7303.48万元。当日关注点来自交易信息汇总：1月9日主力资金净流入674.14万元，显示主力对华仁药业股票的积极介入。来自交易信息汇总：当日发生一笔折价10.09%的大宗交易，合计成交88.2万元，反映部分股东减持意愿。大宗交易1月9日华仁药业现1笔折价10.09%的大宗交易，合计成交88.2万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200001016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"gpt_icon":0},{"id":"2601024251","title":"股市必读：12月31日华仁药业现3笔大宗交易 机构净买入368.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601024251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601024251?lang=zh_cn&edition=full","pubTime":"2026-01-05 04:55","pubTimestamp":1767560108,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，华仁药业报收于3.15元，上涨0.32%，换手率1.3%，成交量15.39万手，成交额4829.61万元。当日关注点来自交易信息汇总：12月31日主力资金净流出368.65万元，占总成交额7.63%。大宗交易12月31日华仁药业发生3笔大宗交易，机构净买入368.26万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500001595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2600060551","title":"每周股票复盘：机构连续两日净买入华仁药业（300110）","url":"https://stock-news.laohu8.com/highlight/detail?id=2600060551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600060551?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:35","pubTimestamp":1767382512,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，华仁药业报收于3.15元，较上周的3.21元下跌1.87%。本周，华仁药业12月29日盘中最高价报3.22元。12月30日盘中最低价报3.11元。华仁药业当前最新总市值37.24亿元，在化学制药板块市值排名118/150，在两市A股市值排名4096/5181。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2595714018","title":"股市必读：12月30日华仁药业现10笔大宗交易 机构净买入1030.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595714018","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595714018?lang=zh_cn&edition=full","pubTime":"2025-12-31 03:34","pubTimestamp":1767123253,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，华仁药业报收于3.14元，下跌0.95%，换手率1.72%，成交量20.32万手，成交额6395.3万元。当日关注点来自交易信息汇总：12月30日主力资金净流入558.62万元，显示主力对华仁药业股票的积极介入。来自交易信息汇总：当日发生10笔大宗交易，机构净买入1030.75万元，反映机构投资者的较强买入意愿。大宗交易12月30日华仁药业发生10笔大宗交易，机构净买入1030.75万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100003959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2594299817","title":"华仁药业：部分生产线已配套使用工业机器人","url":"https://stock-news.laohu8.com/highlight/detail?id=2594299817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594299817?lang=zh_cn&edition=full","pubTime":"2025-12-26 20:51","pubTimestamp":1766753494,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业(300110)12月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的机器人运用在生产线上了吗？华仁药业回复：尊敬的投资者您好，公司部分生产线已配套使用工业机器人，主要用于提升生产自动化水平与效率，相关应用符合智能制造发展方向。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600033263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2593723244","title":"华仁药业：大股东减持计划正在执行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2593723244","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593723244?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:51","pubTimestamp":1766580689,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业(300110)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的大股东减持计划完成了吗？近期是否还有股东变动计划呢？华仁药业回复：尊敬的投资者您好，公司持股5%以上股东华仁世纪集团有限公司减持计划正在执行中。公司将严格遵循信息披露相关规则，及时、准确、完整地向市场披露股东权益变动的相关情况。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400037402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2593472550","title":"华仁药业：此类挂单均属于市场投资者的自主委托行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2593472550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593472550?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:51","pubTimestamp":1766580684,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业(300110)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：解释一下公司这个卖单挂单每天有，2188.4188这样的竞价数量是怎么来的？华仁药业回复：尊敬的投资者您好，此类挂单均属于市场投资者的自主委托行为，公司严格遵守相关法律法规、切实履行信息披露义务，不干预二级市场正常交易。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400037395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"gpt_icon":0},{"id":"2592905783","title":"华仁药业：多索茶碱适用于支气管哮喘","url":"https://stock-news.laohu8.com/highlight/detail?id=2592905783","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592905783?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:51","pubTimestamp":1766062298,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业(300110)12月17日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的多索茶碱不是治疗感冒，为什么董秘说有没冶疗感冒药的药？华仁药业回复：尊敬的投资者您好，公司多索茶碱注射液适用于支气管哮喘、慢性喘息性支气管炎及其他支气管痉挛引起的呼吸困难，属支气管扩张剂，当感冒引发相关特定并发症时，可作为对症治疗药物使用。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800035371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2591984135","title":"华仁药业：截至2025年12月10日股东总户数约为3.97万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2591984135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591984135?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:52","pubTimestamp":1765889526,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业(300110)12月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日股东人数是多少？华仁药业回复：尊敬的投资者您好，截至2025年12月10日，公司股东总户数约为3.97万户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600038104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2590594511","title":"华仁药业（300110）披露持股5%以上股东权益变动触及1%整数倍公告，12月11日股价下跌3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590594511","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590594511?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:58","pubTimestamp":1765447122,"startTime":"0","endTime":"0","summary":"截至2025年12月11日收盘，华仁药业报收于3.25元，较前一交易日下跌3.27%，最新总市值为38.42亿元。公司近日发布公告称，华仁药业股份有限公司于2025年12月10日收到持股5%以上股东华仁世纪集团有限公司的告知函，其于2025年12月8日至12月10日通过集中交易和大宗交易方式累计减持公司股份14,815,900股，占公司总股本的1.25%。本次权益变动后，华仁世纪集团及其一致行动人合计持股比例由6.83%降至5.58%，触及1%整数倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100029471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2590880605","title":"12月10日华仁药业现6笔大宗交易 机构净买入1936.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590880605","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590880605?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:43","pubTimestamp":1765359802,"startTime":"0","endTime":"0","summary":"证券之星消息，12月10日华仁药业发生大宗交易，交易数据如下：近三个月该股共发生6笔大宗交易，合计成交7.43万手，折价成交6笔。该股近期无解禁股上市。截至2025年12月10日收盘，华仁药业(300110)报收于3.36元，下跌0.88%，换手率2.51%，成交量29.67万手，成交额9956.07万元。该股近半年内有股东持股变动，合计净减持2633.23万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000028221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2589950168","title":"华仁药业持股5%以上股东华仁世纪集团减持，持股比例降至6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589950168","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589950168?lang=zh_cn&edition=full","pubTime":"2025-12-05 18:19","pubTimestamp":1764929991,"startTime":"0","endTime":"0","summary":"中访网数据 华仁药业股份有限公司于2025年12月5日收到持股5%以上股东华仁世纪集团有限公司的权益变动告知函。本次权益变动后，华仁世纪集团及其一致行动人合计持有公司股份比例由7.06%减少至6.83%，变动触及1%的整数倍。此次减持是华仁世纪集团根据其于2025年11月13日披露的减持计划进行的，该计划拟在公告之日起十五个交易日后三个月内，通过集中竞价及大宗交易方式减持不超过公司总股本3%的股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251205/31847673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2588283727","title":"华仁药业：截至2025年11月20日股东总户数约为3.94万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588283727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588283727?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:48","pubTimestamp":1764593319,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业(300110)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，请问截止到11月20日的最新股东人数是多少，谢谢！华仁药业回复：尊敬的投资者您好，截至2025年11月20日，公司股东总户数约为3.94万户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100033263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"1180144651","title":"华仁药业股东计划减持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1180144651","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180144651?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:41","pubTimestamp":1763574112,"startTime":"0","endTime":"0","summary":"11月13日 - 华仁药业股份有限公司（300110.SZ）表示，股东计划减持公司最多3%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2583185598","title":"华仁药业(300110.SZ)：华仁世纪集团拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2583185598","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583185598?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:15","pubTimestamp":1763039728,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华仁药业(300110.SZ)发布公告，公司于近日收到持股5%以上股东华仁世纪集团有限公司(简称“华仁世纪集团”)《关于减持华仁药业股份计划的告知函》，华仁世纪集团计划自减持计划公告之日起十五个交易日后的三个月内通过集中竞价交易方式、大宗交易方式减持不超过公司总股本3%的股份，即不超过3546.63万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2582370379","title":"华仁药业：截至2025年11月10日股东户数约4.01万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2582370379","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582370379?lang=zh_cn&edition=full","pubTime":"2025-11-12 20:52","pubTimestamp":1762951970,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业(300110)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年11月10日A股股东人数是多少？谢谢华仁药业回复：尊敬的投资者您好，截至2025年11月10日，公司股东总户数约为4.01万户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200038884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2581006722","title":"华仁药业：强化监督制约机制化解历史风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2581006722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581006722?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:48","pubTimestamp":1762346895,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业(300110)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：公司管理成这样欠下巨额债务，这管理者不能一走了之呀，你们将如何处理？华仁药业回复：尊敬的投资者您好！公司将持续加强内部控制，做好审计监察工作，强化监督制约机制，规范、合规、透明、妥善化解历史风险。同步加强业务合作风险评估及应收账款管理，并基于最大化挽回损失的原则，持续积极跟进债务化解进度，最大程度维护公司及全体股东的合法权益。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500038484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2579211332","title":"华仁药业(300110)10月10日股东户数4.07万户，较上期增加0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579211332","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579211332?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:43","pubTimestamp":1761817426,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华仁药业披露，截至2025年10月10日公司股东户数为4.07万户，较9月30日增加105.0户，增幅为0.26%。在化学制药行业个股中，华仁药业股东户数高于行业平均水平，截至10月10日，化学制药行业平均股东户数为3.43万户。从股价来看，2025年9月30日至2025年10月10日，华仁药业区间跌幅为0.0%，在此期间股东户数增加105.0户，增幅为0.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000034173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2579722905","title":"图解华仁药业三季报：第三季度单季净利润同比下降22.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579722905","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579722905?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:37","pubTimestamp":1761741454,"startTime":"0","endTime":"0","summary":"证券之星消息，华仁药业2025年三季报显示，前三季度公司主营收入9.76亿元，同比下降9.07%；归母净利润5457.98万元，同比下降42.87%；扣非净利润4572.72万元，同比下降49.18%；其中2025年第三季度，公司单季度主营收入3.52亿元，同比上升16.62%；单季度归母净利润1724.69万元，同比下降22.72%；单季度扣非净利润1803.8万元，同比下降18.63%；负债率58.02%，投资收益228.18万元，财务费用3378.4万元，毛利率34.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900041781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110"],"gpt_icon":0},{"id":"2577780258","title":"股市必读：华仁药业(300110)股东户数4.07万户，较上期增加0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577780258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577780258?lang=zh_cn&edition=full","pubTime":"2025-10-22 04:21","pubTimestamp":1761078067,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，华仁药业报收于3.38元，上涨3.05%，换手率2.2%，成交量26.04万手，成交额8695.61万元。当日关注点来自交易信息汇总：10月21日主力资金净流入103.93万元，显示主力小幅加仓。股本股东变化股东户数变动近日华仁药业披露，截至2025年10月10日公司股东户数为4.07万户，较9月20日增加200.0户，增幅为0.49%。户均持股数量由上期的2.92万股减少至2.9万股，户均持股市值为9.44万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200004049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768322522261,"stockEarnings":[{"period":"1week","weight":0.0309},{"period":"1month","weight":0.0437},{"period":"3month","weight":0.0245},{"period":"6month","weight":-0.0402},{"period":"1year","weight":0.003},{"period":"ytd","weight":0.0603}],"compareEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":0.0641},{"period":"3month","weight":0.0579},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.3094},{"period":"ytd","weight":0.0428}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华仁药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"40000人(较上一季度增加0.76%)","perCapita":"29521股","listingDate":"2010-08-25","address":"山东省青岛市崂山区高科技工业园株洲路187号","registeredCapital":"118221万元","survey":"　　华仁药业股份有限公司的主营业务是医药、医疗器械、医用包材、大健康、医药商业流通。公司的主要产品是基础输液、治疗制剂、腹透液、医疗器械、其他。公司是山东省应急储备定点输液生产企业，先后获得“全国AAA级信用企业”“国家知识产权优势/示范企业”“中国化学制药行业工业企业综合实力百强”“中国医药工业百强”“山东省质量管理奖”“山东省高端品牌培育企业”“‘品质鲁药’建设示范企业”等系列荣誉。","listedPrice":13.99},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华仁药业,300110,华仁药业股票,华仁药业股票老虎,华仁药业股票老虎国际,华仁药业行情,华仁药业股票行情,华仁药业股价,华仁药业股市,华仁药业股票价格,华仁药业股票交易,华仁药业股票购买,华仁药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}